drugset / Trial / NCT00570622

Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

NCT00570622

Phase 4 Completed 20 enrolled Medical University of Vienna
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the response to pioglitazone on the hepatic venous pressure gradient and peripheral vascular responsiveness to vasoconstrictors in patients with advanced (Child´s Grade B or C) cirrhosis.

Timeline

Start
2004-12
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pioglitazone Small molecule 60 mg Oral